The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Journal: Evidence-based Cardiology. 2011;(4): 11‑17

Read: 1223 times

Download PDF (RU)
Contact the author
Table of contents

To cite this article:

. Evidence-based Cardiology. 2011;(4):11‑17. (In Russ.)

МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Abstract:

Close metadata

References:

  1. Keeley E., Boura J.A., Grines C.L. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 2003;361:13-20.
  2. Antman E.M., Anbe D.T., Armstrong P.W., et al. American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction). ACC/AHA guidelines for the management of patients with ST elevation myocardial infarction-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction). Circulation 2004;110:588-636.
  3. Flynn A., Moscucci M., Share D., et al. Trends in door-to-balloon time and mortality in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Arch Intern Med 2010;170:1842-1849.
  4. Wang T.Y., Fonarow G.C., Hernandez A.F., et al. The dissociation between door-to-balloon time improvement and improvements in other acute myocardial infarction care processes and patient outcomes. Arch Intern Med 2009;169:1411-1419.
  5. Lloyd-Jones D., Adams R., Carnethon M., et al. American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2009 update:areportfromtheAmericanHeart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2009;119:480-486.
  6. Rezkalla S.H., Kloner R.A. No-reflow phenomenon. Circulation 2002;105:656-662.
  7. Ito H., Maruyama A., Iwakura K., et al. Clinical implications of the 'no reflow' phenomenon: a predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction. Circulation 1996;93:223-228.
  8. Wu E., Ortiz J.T., Tejedor P., et al. Infarct size by contrast enhanced cardiac magnetic resonance is a stronger predictor of outcomes than left ventricular ejection fraction or endsystolic volume index: prospective cohort study. Heart 2008;94:730-736.
  9. Ezekowitz J.A., Armstrong P.W., Granger C.B., et al. Predicting chronic left ventricular dysfunction 90 days after ST-segment elevation myocardial infarction: An Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) substudy. Am Heart J 2010;160:272-278.
  10. Kern M.J., Aguirre F., Bach R., et al. Augmentation of coronary blood flow by intraaortic balloon pumping in patients after coronary angioplasty. Circulation 1993;87:500-511.
  11. Williams D.O., Korr K.S., Gewirtz H., Most A.S. The effect of intraaortic balloon counterpulsationon regional myocardial blood flow and oxygen consumption in the presence of coronary artery stenosis in patients with unstable angina. Circulation 1982;66:593-597.
  12. Sanborn T.A., Sleeper L.A., Bates E.R., et al. Impact of thrombolysis, intra-aortic balloon pump counterpulsation, and their combination in cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry: Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock? J Am Coll Cardiol 2000;36(suppl A):1123-1129.
  13. Hochman J.S., Sleeper L.A., White H.D., et al. SHOCK Investigators (Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock). One-yearsurvivalfollowingearlyrevascularizationforcardiogenicshock. JAMA 2001;285:190-192.
  14. Stone G.W., Marsalese D., Brodie B.R., et al. Second Primary Angioplasty in Myocardial Infarction (PAMI-II) Trial Investigators. A prospective, randomized evaluation of prophylactic intraaortic balloon counterpulsation in high risk patients with acute myocardial infarction treated with primary angioplasty. J Am Coll Cardiol 1997;29:1459-1467.
  15. Brodie B.R., Stuckey T.D., Hansen C., Muncy D. Intraaortic balloon counterpulsation before primary percutaneous transluminal coronary angioplasty reduces catheterization laboratory events in high-risk patients with acute myocardial infarction. Am J Cardiol 1999;84:18-23.
  16. Cohen M., Urban P., Christenson J.T., et al. Benchmark Registry Collaborators. Intra-aortic balloon counterpulsation in US and non-US centres: results of the Benchmark Registry. Eur Heart J 2003;24:1763-1770.
  17. Achour H., Boccalandro F., Felli P., et al. Mechanical left ventricular unloading prior toreperfusion reduces infarct size in a canine infarction model. Catheter Cardiovasc Interv 2005;64:182-192.
  18. LeDoux J.F., Tamareille S., Felli P.R., et al. Left ventricular unloading with intra-aortic counter pulsation prior to reperfusion reduces myocardial release of endothelin-1 and decreases infarction size in a porcine ischemia-reperfusion model. Catheter Cardiovasc Interv 2008;72:513-521.
  19. Azevedo C.F., Amado L.C., Kraitchman D.L., et al. The effect of intra-aortic balloon counterpulsation on left ventricular functional recovery early after acute myocardial infarction: a randomized experimental magnetic resonance imaging study. Eur Heart J 2005;26:1235-1241.
  20. Thiele H., Kappl M.J.E., Conradi S., et al. Reproducibility of chronic and acute infarct size measurement by delayed enhancement-magnetic resonance imaging. J Am Coll Cardiol 2006;47:1641-1645.
  21. Patel M.R., Worthley S.G., Stebbins A., et al. Pexelizumab and infarct size in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: a delayed enhancement cardiac magnetic resonance substudy from the APEX-AMI trial. JACC Cardiovasc Imaging 2010;3:52-60.
  22. Thiele H., Schindler K., Friedenberger J., et al. Intracoronary compared with intravenous bolus abciximab application in patients with ST-elevation myocardial infarction under going primary percutaneous coronary intervention: the randomized Leipzig Immediate Percutaneous Coronary Intervention Abciximab IV Versus IC in ST-Elevation Myocardial Infarction trial. Circulation 2008;118:49-57.
  23. Stone G.W., Dixon S.R., Grines C.L., et al. Predictors of infarct size after primary coronary angioplasty in acute myocardial infarction from pooled analysis from four contemporary trials. Am J Cardiol 2007;100:1370-1375.
  24. Francone M., Bucciarelli-Ducci C., Carbone I., et al. Impact of primary coronary angioplasty delay on myocardial salvage, infarct size, and microvascular damage in patients with ST-segment elevation myocardial infarction: insight from cardiovascular magnetic resonance. J Am Coll Cardiol 2009;54:2145-2153.
  25. Eitel I., Desch S., Fuernau G., et al. Prognostic significance and determinants of myocardial salvage assessed by cardiovascular magnetic resonance in acute reperfused myocardial infarction. J Am Coll Cardiol 2010;55:2470-2479.
  26. Bonnefoy E., Steg P.G., Boutitie F., et al.  CAPTIM Investigators. Comparison of Primary Angioplasty and Pre-Hospital Fibrinolysis in Acute Myocardial Infarction (CAPTIM) trial: a 5-year follow-up. Eur Heart J 2009;30:1598-1606.
  27. Perera D., Stables R., Thomas M., et al. BCIS-1 Investigators. Elective intra-aortic balloon counterpulsation during high-risk percutaneous coronary intervention: a randomized controlled trial. JAMA 2010;304:867-874.
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.